Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gsk Plc ADR
(NY:
GSK
)
45.07
+0.40 (+0.90%)
Official Closing Price
Updated: 7:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gsk Plc ADR
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
31
32
Next >
Stocks That Hit 52-Week Lows On Wednesday
August 10, 2022
During Wednesday, 52 stocks hit new 52-week lows.
Via
Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
August 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
GSK Confirms Rotavirus Vaccine Shortage, Hits Four African Countries: Report
August 10, 2022
Via
Benzinga
Vir Biotech Shuns FDA Submission Plans For GSK-Partnered COVID-19 Treatment
August 10, 2022
Via
Benzinga
Mersana, GSK Ink $1.36B Biobuck Deal For Cancer-Focused Therapy
August 09, 2022
Via
Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
August 09, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Dividend Income Update July 2022
August 09, 2022
The start of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated. Let’s take a look back at...
Via
Talk Markets
ADDING MULTIMEDIA GSK and IQVIA launch Vaccine Track, a data trend platform to help improve adult vaccination in communities nationwide
August 08, 2022
From
GSK plc
Via
Business Wire
Drug Behemoth GSK Delivers Strong Beat And Raise, But Shares Fell
July 27, 2022
The company expects full-year sales to grow 6%-8% and for earnings to rise 1%.
Via
Investor's Business Daily
New GSK Q2 Highlights: Shingles Vaccine Back In Demand, Antibiotics Recover, Forecast Boost
July 27, 2022
Via
Benzinga
Codexis Shares Slide On CEO Transition
July 18, 2022
Via
Benzinga
Biotech Investors: August's Key PDUFA Catalysts You Must Know
July 31, 2022
Regulatory decisions have yet to pick up pace this year. July’s calendar was light, but the good news was that most decisions turned out to be positive. That said, none of the drugs approved during the...
Via
Benzinga
Recap Of Friday's Biotech Catalysts - End of The Day Summary
July 29, 2022
Via
Benzinga
Stock Market Rally Powers Higher On Fed Rate Hints; Apple, Microsoft, Meta, Amazon, Google Key Earnings: Weekly Review
July 29, 2022
The major indexes made big moves amid key earnings and another big Fed rate hike.
Via
Investor's Business Daily
GSK Completes Spin Off Of Its Consumer Healthcare Business
July 18, 2022
Via
Benzinga
Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate
July 28, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Recap of Wednesday's Biotech Catalysts - End of The Day Summary
July 27, 2022
Via
Benzinga
GSK Announces US FDA Approval of Benlysta (Belimumab) for Pediatric Patients With Active Lupus Nephritis
July 27, 2022
From
GSK plc
Via
Business Wire
IDEAYA's Cancer Candidate Shows Early Tumor Modulation
July 27, 2022
Via
Benzinga
The 3 Best Market Sectors for the Second Half of 2022
July 27, 2022
Compelling themes will drive a recovery in some sectors over the second half of 2022. The following are the best market sectors to buy into.
Via
InvestorPlace
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
July 27, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Jim Cramer Says This Stock Costs About $3, But 'If You Wait Long Enough' You Can Buy It For $2
July 27, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Blackstone Inc. (NYSE: BX) over Apollo Global Management Inc (NYSE: APO).
Via
Benzinga
Benzinga Before The Bell: Twitter Shareholder Proposal Date Set, T-Mobile's Strong FY22 Outlook, Shopify's Job Cuts And Other Top Financial Stories Wednesday, July 27
July 27, 2022
Reuters Monkeypox Emergency Could Last Months, According To Experts
Via
Benzinga
7 Dividend Stocks to Buy on the Dip
July 27, 2022
The stock market is volatile and bottoming, making it a good time to buy dividend stocks on the dip. Here are seven worth your consideration.
Via
InvestorPlace
This Analyst Says GSK Spin-Off Haleon Offers "Best Of Both Consumer Worlds"
July 22, 2022
Citi group has initiated coverage on GSK plc's (NYSE: GSK) consumer healthcare spin-off Haleon Plc (NYSE: HLN) with a Buy rating and a price target of 360p.
Via
Benzinga
3 Biotech Stocks to Buy on the Dip
July 21, 2022
Biotech stocks have rebounded lately and are poised to keep surging, so it's a good time to buy biotech stocks on the dip.
Via
InvestorPlace
Benzinga Before The Bell: Musk's Twitter Lawsuit, Uber Penalized For Overcharging People With Disabilities, Johnson & Johnson Cuts Outlook And Other Top Financial Stories Tuesday, July 19
July 19, 2022
CNBC Amazon Courts More Trouble As Regulators Inspect Its Warehouses
Via
Benzinga
Post Mega London Stock Exchange Listing, GSK Spinoff Haleon's Plunge Brings Valuation Concerns To The Fore
July 19, 2022
After GSK (NYSE: GSK) spun off its consumer health division Haleon Plc (LSE: HLN) into a separate entity, shares of the newly listed firm plunged during intraday trade, closing over 6.5% down at...
Via
Benzinga
Air Pollution is a Global Heart and Lung Health Concern
July 18, 2022
Palm Beach, FL – July 18, 2022 – FinancialNewsMedia.com News Commentary – Particulate matter or particle pollution is a significant contributor to heart and lung disease. Individuals most affected by...
Via
FinancialNewsMedia
Topics
Climate Change
Emissions
Energy
Exposures
Climate
Fossil Fuels
Benzinga Before The Bell: Amazon Wages Price War On Tesco, Biden's Campaign Promise To Free Cannabis Prisoners, H&M Exits Russia And Other Top Financial Stories Monday, July 18
July 18, 2022
Reuters GSK Completes Spin-Off Of Its Consumer Healthcare Business
Via
Benzinga
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.